Correlation Between Briacell Therapeutics and Fidelity Advisor

Can any of the company-specific risk be diversified away by investing in both Briacell Therapeutics and Fidelity Advisor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Briacell Therapeutics and Fidelity Advisor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Briacell Therapeutics Corp and Fidelity Advisor Communication, you can compare the effects of market volatilities on Briacell Therapeutics and Fidelity Advisor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Briacell Therapeutics with a short position of Fidelity Advisor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Briacell Therapeutics and Fidelity Advisor.

Diversification Opportunities for Briacell Therapeutics and Fidelity Advisor

-0.72

Correlation Coefficient

Briacell Therapeutics  Fidelity Advisor

Pay attention - limited upside

The 3 months correlation between Briacell and Fidelity is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Briacell Therapeutics Corp and Fidelity Advisor Communication in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity Advisor Com and Briacell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Briacell Therapeutics Corp are associated (or correlated) with Fidelity Advisor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity Advisor Com has no effect on the direction of Briacell Therapeutics i.e., Briacell Therapeutics and Fidelity Advisor go up and down completely randomly.

Pair Corralation between Briacell Therapeutics and Fidelity Advisor

Given the investment horizon of 90 days Briacell Therapeutics Corp is expected to under-perform the Fidelity Advisor. In addition to that, Briacell Therapeutics is 3.06 times more volatile than Fidelity Advisor Communication. It trades about -0.15 of its total potential returns per unit of risk. Fidelity Advisor Communication is currently generating about -0.12 per unit of volatility. If you would invest  9,470  in Fidelity Advisor Communication on January 27, 2024 and sell it today you would lose (393.00) from holding Fidelity Advisor Communication or give up 4.15% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Briacell Therapeutics Corp  vs.  Fidelity Advisor Communication

Briacell Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Briacell Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Fidelity Advisor Com

Risk-Adjusted Performance

0 of 100

Insignificant

Over the last 90 days Fidelity Advisor Communication has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong primary indicators, Fidelity Advisor is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Briacell Therapeutics and Fidelity Advisor

The main advantage of trading using opposite Briacell Therapeutics and Fidelity Advisor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Briacell Therapeutics position performs unexpectedly, Fidelity Advisor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity Advisor will offset losses from the drop in Fidelity Advisor's long position.

The idea behind Briacell Therapeutics Corp and Fidelity Advisor Communication pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.